Log in Register

Log in

image
About NCMLSG
The aim and purpose of the NCMLSG 

is to promote better treatment for patients with chronic myeloid leukemia

Read more
  • Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial +

    Dear Colleagues,

    We are glad to inform you that our manuscript „Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial” was published electronically on May 4, 2018 ahead of print at THE LANCET ONCOLOGY.

    We thank you all for this tremendous work, for your input and support.

    https://www.ncbi.nlm.nih.gov/pubmed/29735299

     

    Best regards,

     

    Francois Mahon               Susanne Saußele             Markus Pfirrmann           Johann Richter                 Joelle Guilhot

    Read More
  • REIMBURSEMENT FORM/Nordic CML Study Group +

    In order to receive reimbursement for expenses regarding participation in NCMLSG meetings, please use this form as an enclosure when submitting the original receipts. Preferably fill in the form with a computer or a typewriter.

    Read More
  • 1

Login